WJPPS Citation Report

Submit Article

Search

News & Updation

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: New Impact Factor 2026
  • WJPPS Impact Factor has been Increased to 8.485 for Year 2026.

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2026 Issue has been successfully launched on 1 NOVEMBER 2026.

Abstract

POLYMERIC MATRIX SYSTEMS FOR NON-INVASIVE ORAL DELIVERY OF MACROMOLECULAR THERAPEUTICS: RECENT ADVANCES AND FUTURE PERSPECTIVES

Nupur Patel*, Nisha Patel, Maitri Patel, Mosam Patel, Anu Viral Patel

ABSTRACT

Peptides, proteins, oligonucleotides and vaccine antigens are important therapeutic molecules because they can act on specific targets in the body. However, many of these medicines are given by injection because the gastrointestinal (GI) tract can damage them or prevent them from reaching the bloodstream. Stomach acid, digestive enzymes, mucus, the intestinal lining, drug efflux and metabolism before the drug reaches the circulation all limit oral absorption.[1–6] Polymeric matrix systems are being investigated as a way to protect these molecules, control drug release and help formulations reach the intended part of the GI tract.[7–14] This review discusses natural, semi-synthetic and synthetic polymers, along with tablets, hydrogels, films, micro- and nanoparticles, and combined delivery systems. It also considers manufacturing, quality testing, drug-release models and the challenges involved in translating laboratory findings into clinical use. Chitosan, alginate, pectin, cellulose derivatives, polyethylene glycol (PEG), poly(lactic-co-glycolic acid) (PLGA) and pH-responsive polymers each offer useful properties, such as mucoadhesion, swelling, degradation or site-specific release.[8–18] Despite these advantages, improved protection or movement through a laboratory model does not guarantee effective absorption in humans. Oral semaglutide demonstrates that a particular peptide can be administered orally when the formulation is carefully designed and includes an absorption enhancer. It does not establish that polymer matrices alone can make all biological medicines suitable for oral use.[19,20] Future progress will require drug-specific formulation design, reliable manufacturing, tests that confirm biological activity, realistic laboratory models and stronger links between in-vitro results and drug behaviour in people.

Keywords: Oral delivery of large molecules; polymeric matrix; peptides; proteins; chitosan; alginate; nanoparticles; mucoadhesion; controlled release; bioavailability.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More